Clinical Trials in Shiyan, Hubei
22 recruiting
Showing 1–20 of 21 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Merck Sharp & Dohme LLC1,200 enrolled499 locationsNCT06430801
Recruiting
Phase 3
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeOne Medicines150 enrolled64 locationsNCT06970743
Recruiting
Phase 3
Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage
Intracerebral Hemorrhage
Beijing Tiantan Hospital1,192 enrolled41 locationsNCT07338175
Recruiting
Phase 2Phase 3
Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria
Chronic Spontaneous Urticaria (CSU)
Beijing InnoCare Pharma Tech Co., Ltd.344 enrolled30 locationsNCT07378527
Recruiting
Phase 2
A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis
Generalized Pustular Psoriasis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.36 enrolled32 locationsNCT07314060
Recruiting
Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Hoffmann-La Roche1,000 enrolled41 locationsNCT06439576
Recruiting
Not Applicable
Effects of Vitamin D3 and Yeast Beta-Glucan Supplementation on Glycemic Control and Cardiovascular Disease Risk in Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
Huazhong University of Science and Technology2,500 enrolled5 locationsNCT06861062
Recruiting
Phase 3
A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects
Plaque Psoriasis
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.537 enrolled55 locationsNCT07357831
Recruiting
Not Applicable
A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)
Renal Anemia of Chronic Kidney Disease
Guangdong Provincial People's Hospital96 enrolled24 locationsNCT07136792
Recruiting
Not Applicable
Thumbtack Needle in the Treatment of NVP
Nausea and Vomiting in Pregnancy (NVP)
Dongmei Huang320 enrolled13 locationsNCT06566274
Recruiting
A Mixed Cohort, Multicentre Exploratory Study of Non-invasive Quantitative Assessment of Renal Graft Function With Non-contrast Functional Magnetic Resonance Imaging
Kidney TransplantRenal Allograft RecipientsRenal Allograft
Tongji Hospital1,000 enrolled3 locationsNCT07333495
Recruiting
Phase 3
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Primary Biliary Cholangitis
Cascade Pharmaceuticals, Inc135 enrolled41 locationsNCT07282353
Recruiting
Phase 3
A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia
Hyperkalemia
Waterstone Pharmaceutical (Wuhan) Co., LTD.420 enrolled50 locationsNCT07251309
Recruiting
Phase 2
F573 for Injection for the Treatment of Liver Injury/Failure
Acute-On-Chronic Liver FailureAcute Liver Failure
Beijing Continent Pharmaceutical Co, Ltd.97 enrolled10 locationsNCT05689645
Recruiting
Not Applicable
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
Deep LearningIntracranial AneurysmCT Angiography+1 more
Jinling Hospital, China6,450 enrolled21 locationsNCT06118840
Recruiting
Phase 1Phase 2
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Chipscreen Biosciences, Ltd.220 enrolled11 locationsNCT07129382
Recruiting
Phase 3
Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
Non-Proliferative Diabetic Retinopathy
Beletalent (Zhuhai) Pharmaceutical Co., Ltd360 enrolled30 locationsNCT06817265
Recruiting
The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus
Cognitive Dysfunction
Tongji Hospital5,000 enrolled21 locationsNCT07128186
Recruiting
Phase 2Phase 3
ICP-332 in Subjects With Non-segmental Vitiligo
Non-segmental Vitiligo
Beijing InnoCare Pharma Tech Co., Ltd.603 enrolled45 locationsNCT07047612
Recruiting
Phase 4
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
Atherosclerotic PlaqueIntracranial AtherosclerosisIntracranial Artery Stenosis
Peking Union Medical College Hospital300 enrolled19 locationsNCT06902740